Zolpidem tartrate tablets ip?

Are you asking for the Indian Pharmacopoeia (IP) monograph details for Zolpidem Tartrate Tablets (IP), or just general information about Zolpidem tartrate tablets?

If you want a quick overview:
- Zolpidem tartrate tablets IP refer to the IP-standard, short-acting hypnotic tablets containing zolpidem tartrate.
- Typical strengths in IP formulations are 5 mg and 10 mg of zolpidem per tablet (as the tartrate salt).
- They are used for short-term treatment of insomnia in adults.
- Common dosing (general guidance, not a substitute for labeling): 5 mg to 10 mg taken immediately before bedtime; lower dose (5 mg) is preferred for women and elderly; do not exceed 10 mg daily.
- Important safety: can cause next-day drowsiness, memory impairment, complex sleep behaviors, and interact with alcohol or other CNS depressants. Not for use in pregnancy unless clearly needed. Use with caution in elderly or hepatic impairment.
- Regulatory note: zolpidem is a prescription drug and is typically subject to strict regulatory controls in most countries, including India.

If you need the exact IP monograph (identification, assay, dissolution specifications, impurities, etc.), please tell me:
- The IP edition/year you’re using (e.g., IP 1st/2nd edition, latest edition).
- Whether you want the 5 mg or 10 mg strength, or both.

I can then guide you on where to find the exact IP specification or summarize the monograph content once you provide the edition.